These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Benzothiazole Derivative as a Novel Mycobacterium tuberculosis Shikimate Kinase Inhibitor: Identification and Elucidation of Its Allosteric Mode of Inhibition. Mehra R; Rajput VS; Gupta M; Chib R; Kumar A; Wazir P; Khan IA; Nargotra A J Chem Inf Model; 2016 May; 56(5):930-40. PubMed ID: 27149193 [TBL] [Abstract][Full Text] [Related]
7. Shikimate Kinase Inhibitors: An Update on Promising Strategy against Rajput VS; Runthala A; Khan IA Curr Drug Targets; 2023; 24(5):388-405. PubMed ID: 36752299 [TBL] [Abstract][Full Text] [Related]
8. Identification of novel antimicrobial compounds targeting Mycobacterium tuberculosis shikimate kinase using in silico hierarchical structure-based drug screening. Kawamoto S; Hori C; Taniguchi H; Okubo S; Aoki S Tuberculosis (Edinb); 2023 Jul; 141():102362. PubMed ID: 37311288 [TBL] [Abstract][Full Text] [Related]
9. Toxicological Profiling of Potential Shikimate Kinase Inhibitors Against Jhangiani A; Panda V; Sukheja A; Thomas S; Dusseja P; Pandya S; Chintakrindi A Altern Lab Anim; 2024 Jan; 52(1):10-27. PubMed ID: 38095084 [TBL] [Abstract][Full Text] [Related]
10. An overview of mechanism and chemical inhibitors of shikimate kinase. Chagaleti BK; Reddy MBR; Saravanan V; B S; D P; Senthil Kumar P; Kathiravan MK J Biomol Struct Dyn; 2023; 41(23):14582-14598. PubMed ID: 36974959 [TBL] [Abstract][Full Text] [Related]
11. Structure-based in silico design of a high-affinity dipeptide inhibitor for novel protein drug target Shikimate kinase of Mycobacterium tuberculosis. Kumar M; Verma S; Sharma S; Srinivasan A; Singh TP; Kaur P Chem Biol Drug Des; 2010 Sep; 76(3):277-84. PubMed ID: 20626408 [TBL] [Abstract][Full Text] [Related]
12. Structure of shikimate kinase from Mycobacterium tuberculosis reveals the binding of shikimic acid. Pereira JH; de Oliveira JS; Canduri F; Dias MV; Palma MS; Basso LA; Santos DS; de Azevedo WF Acta Crystallogr D Biol Crystallogr; 2004 Dec; 60(Pt 12 Pt 2):2310-9. PubMed ID: 15583379 [TBL] [Abstract][Full Text] [Related]
13. Crystal structure of Mycobacterium tuberculosis shikimate kinase in complex with shikimic acid and an ATP analogue. Gan J; Gu Y; Li Y; Yan H; Ji X Biochemistry; 2006 Jul; 45(28):8539-45. PubMed ID: 16834327 [TBL] [Abstract][Full Text] [Related]
14. Mechanism of irreversible inhibition of Mycobacterium tuberculosis shikimate kinase by ilimaquinone. Simithy J; Fuanta NR; Hobrath JV; Kochanowska-Karamyan A; Hamann MT; Goodwin DC; Calderón AI Biochim Biophys Acta Proteins Proteom; 2018; 1866(5-6):731-739. PubMed ID: 29654976 [TBL] [Abstract][Full Text] [Related]
15. Development of an ESI-LC-MS-based assay for kinetic evaluation of Mycobacterium tuberculosis shikimate kinase activity and inhibition. Simithy J; Gill G; Wang Y; Goodwin DC; Calderón AI Anal Chem; 2015 Feb; 87(4):2129-36. PubMed ID: 25629762 [TBL] [Abstract][Full Text] [Related]
16. Interaction of shikimic acid with shikimate kinase. Pereira JH; de Oliveira JS; Canduri F; Dias MV; Palma MS; Basso LA; de Azevedo WF; Santos DS Biochem Biophys Res Commun; 2004 Dec; 325(1):10-7. PubMed ID: 15522194 [TBL] [Abstract][Full Text] [Related]
17. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis. Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494 [TBL] [Abstract][Full Text] [Related]
18. Structure-based Discovery of Narirutin as a Shikimate kinase Inhibitor with Anti-tubercular Potency. Sahu PK; Mohapatra PK; Rajani DP; Raval MK Curr Comput Aided Drug Des; 2020; 16(5):523-529. PubMed ID: 31654517 [TBL] [Abstract][Full Text] [Related]
19. [Recent progress in mycobacteriology]. Okada M; Kobayashi K Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602 [TBL] [Abstract][Full Text] [Related]
20. Identification of new potential Mycobacterium tuberculosis shikimate kinase inhibitors through molecular docking simulations. Vianna CP; de Azevedo WF J Mol Model; 2012 Feb; 18(2):755-64. PubMed ID: 21594693 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]